Dehydroemetine
Dehydroemetine is a synthetically produced antiprotozoal agent similar to emetine in its anti-amoebic properties and structure (they differ only in a double bond next to the ethyl substituent), but it produces fewer side effects. In the United States, it is manufactured by Roche. Mechanism Its exact mechanism is not known, but ''in vitro'' it inhibits translocation. Uses It was at one-time, but is no longer distributed by the Center for Disease Control on a compassionate use basis as an investigational drug for the treatment of metronidazole-resistant amoebiasis. Amoebic infections Some examples of the use of dehydroemetine in the treatment of amoebic infections include: # In 1993, the successful treatment of cutaneous amebiasis in a 7-year-old girl with dehydroemetine and metronidazole in Mexico. # A double-blind study of oral dehydroemetine in the treatment of amoebiasis performed at St. Mary's Hospital, Catholic Medical College, Seoul, Republic of Korea in 1973-1974 showed ...
[...More Info...]       [...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]